Liver cancer remains a challenge of global health, being the 4th leading cause of cancer
death worldwide. Hepatocellular carcinoma (HCC) is the most common type of primary liver …

At the beginning of the twentieth century, hepatocellular cancer (HCC) was thought to be
uncommon, and almost nothing was known of its origin or pathogenesis. At the end of the …

Hepatocellular carcinoma (HCC) is the most frequent primary malignancy of the liver, most
prevalent in Asia and Africa but also showing a rising incidence worldwide. Chronic hepatitis …

Hepatocellular carcinoma (HCC) is a major health problem and a leading cause of mortality
among patients with cirrhosis. It is the sixth most common neoplasm worldwide and the third …

Objective. To investigate the risk factors, clinical characteristics, treatment modalities, and
outcomes in Saudi patients with HCC and propose points for early detection of the disease …

Hepatocellular carcinoma (HCC) is one of the few cancers with a 5-year survival that
remains below 20% and an incidence-to-mortality ratio that approaches one. Poor prognosis …

There is a large body of knowledge about HCC causes, pathophysiological mechanisms,
and associated biology and biochemistry. Despite all this, too many patients present for …

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths
worldwide. HCC represents more than 90% of primary liver cancers. There is a growing …

Chronic hepatitis B (CHB) virus infection can cause persistent hepatic inflammation and
cirrhosis, which may lead to hepatocellular carcinoma (HCC). CHB is considered the …

Hepatocellular carcinoma accounts for approximately 75% of all primary liver malignancies.
Several hepatic diseases have been associated with the development of HCC, including …